Biomet Trades Over $44

For a company that makes spinal implants, you’d think Biomet‘s (BMET) board would have a backbone. Apparently not.
The good news is that shares of BMET are now trading above private equity’s $44 offer price. I hope this means the market expects a higher bid. Shareholders will vote on the offer this Friday.

Posted by on June 4th, 2007 at 10:42 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.